A recent article published by Clinical Reference Lab and ExamOne showed the protective value for tobacco testing exceeded $4 billion. Using the same time frame (2015-2022) and 18 million record dataset, we now describe the additional value associated with testing for undiagnosed diabetes and hypertension worth $2.6 billion.